Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber
The Journal of Allergy and Clinical Immunology: In Practice Feb 12, 2018
Bousquet J, et al. - Given that a fixed-dose combination of intranasal azelastine hydrochloride–fluticasone propionate (MP-AzeFlu) is the most effective treatment of allergic rhinitis (AR), researchers herein compared onset of action of MP-AzeFlu with the free combination of oral loratadine and intranasal fluticasone propionate (LORA/INFP). Compared with LORA/INFP, MP-AzeFlu showed more efficacy and had a more rapid onset of action (5 minutes).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
